Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer
Background and Objectives Near‐infrared (NIR) fluorescence optical imaging is a promising technique to assess the tumor margins during cancer surgery. This technique requires targeting by specific fluorescence agents to differentiate tumor from normal surrounding tissue. We assessed the feasibility...
Saved in:
Published in | Journal of surgical oncology Vol. 105; no. 7; pp. 714 - 718 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.06.2012
|
Subjects | |
Online Access | Get full text |
ISSN | 0022-4790 1096-9098 1096-9098 |
DOI | 10.1002/jso.22102 |
Cover
Summary: | Background and Objectives
Near‐infrared (NIR) fluorescence optical imaging is a promising technique to assess the tumor margins during cancer surgery. This technique requires targeting by specific fluorescence agents to differentiate tumor from normal surrounding tissue. We assessed the feasibility of cancer detection using NIR fluorescence agents that target either αvβ3 integrins or the enhanced permeability and retention (EPR) effect in an orthotopic mouse model of oral cancer.
Methods
Binding of the integrin‐targeted agent to tumor cells was assessed in vitro. Oral cancer was induced in 6 BALB/c nu/nu mice by submucosal inoculation of human OSC19‐luc cells into the tongue. Tumor growth was followed with bioluminescence imaging. A combination of agents targeting integrins or EPR effect was injected followed by fluorescence imaging in vivo and ex vivo after resection of the tongues.
Results
Oral cancer was clearly demarcated in vitro; in vivo; and on histological analysis with sufficient tumor‐to‐background ratios of the contrast agents.
Conclusion
This study demonstrates the feasibility of optical imaging of oral squamous cell carcinoma based on targeting of αvβ3 integrins and the EPR effect. Once these NIR fluorescence agents become available for clinical testing, optical image‐guided surgery could reduce residual disease after oral cancer surgery. J. Surg. Oncol. 2012; 105:714–718. © 2011 Wiley Periodicals, Inc. |
---|---|
Bibliography: | istex:62E0A2F9BD8023E5F0FF087C8CCAB01BC4383918 ArticleID:JSO22102 Presentations: This report was presented as an oral presentation at the 3rd World Congress of the International Academy of Oral Oncology (IAOO), Singapore, July 2011, and as an oral presentation at the 6th European Molecular Imaging Meeting (EMIM) of the European Society for Molecular Imaging (ESMI), Leiden, The Netherlands, June 2011. ark:/67375/WNG-0FTC5BXS-2 Conflict of Interest Statement: The authors declare that they have no conflict of interest. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0022-4790 1096-9098 1096-9098 |
DOI: | 10.1002/jso.22102 |